These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Ventricular pre-excitation: electrophysiopathology, criteria for interpretation and clinical diagnosis. References for geriatrics]. Tamburrini LR; Fontanelli A; Primossi G Minerva Cardioangiol; 2001 Feb; 49(1):47-73. PubMed ID: 11279385 [TBL] [Abstract][Full Text] [Related]
3. [Wolff-Parkinson-White syndrome. Value of transesophageal atrial stimulation coupled with exercise test for the study of anterograde conduction in the accessory pathway]. Cebron JP; Le Marec H; Victor J; Chevallier JC; Borgat C; Godin JF Arch Mal Coeur Vaiss; 1989 Feb; 82(2):159-66. PubMed ID: 2500076 [TBL] [Abstract][Full Text] [Related]
4. ["Malignant Kent" arrhythmia, clinical case and literature review]. Baroud I; Pesch C; Beissel J Rev Med Brux; 1996 Apr; 17(2):51-6. PubMed ID: 8685548 [TBL] [Abstract][Full Text] [Related]
5. Electrocardiographic clues for multiple accessory pathways in patients with pre-excitation syndromes. Akiyama T J Am Coll Cardiol; 1990 Oct; 16(4):1029-31. PubMed ID: 2278570 [No Abstract] [Full Text] [Related]
6. Atrial flutter with 1:1 conduction in undiagnosed Wolff-Parkinson-White syndrome. Nelson JG; Zhu DW J Emerg Med; 2014 May; 46(5):e135-40. PubMed ID: 24440627 [TBL] [Abstract][Full Text] [Related]
7. Caveats in preexcitation-related atrial fibrillation. Jolobe OM Am J Emerg Med; 2010 Feb; 28(2):252-3. PubMed ID: 20159403 [No Abstract] [Full Text] [Related]
8. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy]. Duckeck W; Kuck KH Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253 [TBL] [Abstract][Full Text] [Related]
9. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome]. Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293 [TBL] [Abstract][Full Text] [Related]
11. Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathway. Wellens HJ; Bär FW; Gorgels AP; Vanagt EJ Am J Cardiol; 1980 Jan; 45(1):130-3. PubMed ID: 7350760 [TBL] [Abstract][Full Text] [Related]
13. [Localization of the accessory pathways using surface ECG in Wolff-Parkinson-White syndrome]. Di Biase M; Tritto M; Pitzalis MV; Favale S; Rizzon P Cardiologia; 1991 Aug; 36(8 Suppl):71-4. PubMed ID: 1817774 [TBL] [Abstract][Full Text] [Related]
14. [The occurrence of myocardial infarct against a background of the Wolf-Parkinson-White and premature ventricular repolarization syndromes]. Shul'man VA; Nazarov BV; Matiushin GV; Semenov AE; Bol'shakova TIu; Zal'tsberg SV Kardiologiia; 1993; 33(3):93-4. PubMed ID: 8377351 [No Abstract] [Full Text] [Related]
15. Supernormal conduction in the anomalous bundles of the Wolff-Parkinson-White syndrome: an overlooked electrophysiologic property with potential clinical implications. Chiale PA; Albino E; Garro HA; Selva H; Levi RJ; Sánchez RA; Elizari MV; Alvarez CB J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):181-91. PubMed ID: 17875945 [TBL] [Abstract][Full Text] [Related]